Cannabinoid as Potential Aromatase Inhibitor Through Molecular Modeling and Screening for Anti-Cancer Activity

@article{Baroi2020CannabinoidAP,
  title={Cannabinoid as Potential Aromatase Inhibitor Through Molecular Modeling and Screening for Anti-Cancer Activity},
  author={Sudipta Baroi and Achintya Saha and Ritesh Bachar and Sitesh C. Bachar},
  journal={Dhaka University Journal of Pharmaceutical Sciences},
  year={2020},
  volume={19},
  pages={47-58}
}
Inhibition of aromatase (CYTP450), a key enzyme in the estrogen biosynthesis, could result in regression of estrogen-dependent tumors and even prevent the promotion of breast cancer. The present research has been designed for searching a potent chemical moiety from natural sources to inhibit aromatase enzyme, the overfunctionality of which causes the breast cancer. Cannabis sativa contains a very much promising group of cannabinoids with more than 66 compounds with reported anticancer property… 

Figures and Tables from this paper

Cannabis sativa: Interdisciplinary Strategies and Avenues for Medical and Commercial Progression Outside of CBD and THC
TLDR
This review summarises the lengthy history of Cannabis and details the molecular pathways that underpin the production of key secondary metabolites that may confer medical efficacy, and explores additional avenues for the potential improvement of the medical potential of the Cannabis plant.
Marijuana Is Associated With a Hormonal Imbalance Among Several Habits Related to Male Infertility: A Retrospective Study
TLDR
Marijuana is associated with hormonal imbalance in this infertile cohort by lowering estradiol levels and inhibiting aromatase function.

References

SHOWING 1-10 OF 40 REFERENCES
Binding features of steroidal and nonsteroidal inhibitors
Molecular basis for the aromatization reaction and exemestane-mediated irreversible inhibition of human aromatase.
TLDR
Structural basis of the aromatization reaction and drug recognition by aromatase has remained elusive because of its unknown three-dimensional structure, and a new clamping mechanism of substrate/exemestane binding to the active site is proposed.
Use of aromatase inhibitors in breast carcinoma.
TLDR
The evidence supporting the notion that aromatase inhibitors lack cross-resistance with antiestrogens is discussed and the newer, more potent compounds may have a particular application in breast cancer treatment in a setting of adaptive hypersensitivity to estrogens.
The discovery and mechanism of action of letrozole
  • A. Bhatnagar
  • Biology
    Breast Cancer Research and Treatment
  • 2007
TLDR
The discovery of letrozole (Femara®) achieved the goal of discovering a highly potent and totally selective AI and is associated with greater suppression of estrogen than is achieved with other AIs.
Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies.
Structural basis for androgen specificity and oestrogen synthesis in human aromatase
TLDR
The crystal structure of human placental aromatase is presented, the only natural mammalian, full-length P450 and P450 in hormone biosynthetic pathways to be crystallized so far, and the molecular basis for the enzyme’s androgenic specificity and unique catalytic mechanism can be used for developing next-generation aromatases inhibitors.
The potential of aromatase inhibitors in breast cancer prevention.
TLDR
The hypothesis is that breast tissue estrogen levels, as a result of in situ synthesis, are much higher than previously thought and provide a strong rationale for studies of aromatase inhibitors to prevent breast cancer.
Binding characteristics of seven inhibitors of human aromatase: a site-directed mutagenesis study.
TLDR
In this study, eight human aromatase mutants were prepared to evaluate the active site and a proposed hydrophobic pocket of the enzyme that exists in an aromat enzyme model based on the X-ray structure of cytochrome P450cam.
Aromatase and breast cancer.
  • S. Chen
  • Biology
    Frontiers in bioscience : a journal and virtual library
  • 1998
TLDR
The study provides a molecular basis as to why isoflavones are significantly poorer inhibitors of aromatase than flavones, and will help to determine which fruits and vegetables should be included in the diet of postmenopausal women in order to reduce the incidence for breast cancer by inhibiting estrogen biosynthesis in breast tissue.
...
1
2
3
4
...